Eternal founder Deepinder Goyal is stepping beyond the boundaries of food delivery and technology with a bold scientific venture. His longevity-focused initiative, Continue Research, is expanding with a $25 million fund—personally backed by Goyal—to support scientists who “dare to ask simpler questions” about biology and aging.
The expansion builds on a two-year research program that Goyal and his team quietly pursued under Continue. What started as a curiosity-driven project rooted in a “penny-drop insight” into human aging has evolved into a broader, global effort to uncover the underlying principles that govern how and why we age.
“We’re nearing the tail end of research on our central hypothesis,” Goyal said, teasing an upcoming announcement. While the details remain under wraps, he hinted that the hypothesis may reveal something “hiding in plain sight”—a concept that could reframe the scientific understanding of longevity.
Credits: Ascendants
The Quest for Simplicity in Biology
In an age where scientific inquiry often leans into complexity, Goyal’s approach is strikingly contrarian. The Continue Research Fund aims to empower researchers who believe that “biology might be far simpler than we’ve made it.”
“If the human body is a system, it should have leverage points—the simple levers that, when adjusted, could fundamentally alter how we age and live,” Goyal explained.
This philosophy—seeking clarity over complexity—sits at the heart of Continue’s mission. Instead of chasing intricate networks of data and molecules, the initiative calls for a return to first-principles biology: straightforward cause-and-effect reasoning that cuts through the noise.
The fund, Goyal said, will back scientists across the world who share this mindset, supporting projects that prioritize curiosity, discipline, and simplicity over scale. It’s not just a financial move—it’s an intellectual challenge to the way modern science thinks about life itself.
Longevity as a Lever for Humanity
While Continue Research is deeply rooted in biology, its motivation is profoundly philosophical. Goyal has long argued that many of humanity’s problems stem from our short life spans and the short-term thinking they encourage.
“For over a decade, I have believed that most of the world’s problems stem from our short human lifespans,” he wrote in his announcement. “Continue’s goal is to extend healthy function long enough that humans stop making short-term decisions.”
The idea is audacious: by extending healthy human life, Goyal believes we might expand the collective time horizon of civilization itself. If people and institutions could think in terms of centuries instead of decades, decision-making could become more sustainable, strategic, and humane.
Goyal even describes this work as part of humanity’s “journey of conscious evolution,” hinting at what he calls a “Post-Darwin era.” The phrase suggests a vision of a future where humans take active control of their biological destiny rather than being bound by evolutionary limits.
Credits: Business Today
Opening the Doors to Researchers
With the new fund, Continue Research is inviting scientists worldwide to join the effort. Applications are open at continue.com/researchers, offering grants to researchers who align with the project’s first-principles framework.
Importantly, Goyal clarified that Continue is not part of Eternal, the company he’s better known for. Instead, it’s a distinct, mission-driven effort focused purely on the science of aging and human longevity.
Over the next few weeks, Continue Research plans to unveil the findings from its initial two-year inquiry—work that could challenge long-held assumptions about what drives aging. For now, the $25 million fund marks a transition from closed-door exploration to open collaboration, positioning Continue as a bridge between deep curiosity and disciplined discovery.
In a field often dominated by hype and complexity, Deepinder Goyal’s bet on simplicity might just be the disruption longevity science has been waiting for.
